MedinCell S.A. (MDCLF)
USD 6.98
(0.0%)
USD 6.98
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 50.54 Million EUR | 331.68% |
| 2023 | 14.25 Million EUR | -25.56% |
| 2022 | 19.14 Million EUR | -51.86% |
| 2021 | 39.77 Million EUR | 24.06% |
| 2020 | 32.06 Million EUR | 35.8% |
| 2019 | 23.6 Million EUR | -17.72% |
| 2018 | 28.69 Million EUR | 44.38% |
| 2017 | 19.87 Million EUR | 652.2% |
| 2016 | 2.64 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 56 Million EUR | 358.31% |
| 2024 Q2 | 50.83 Million EUR | 0.0% |
| 2024 Q3 | 58.54 Million EUR | 4.9% |
| 2024 Q4 | 50.54 Million EUR | -10.21% |
| 2024 FY | 50.54 Million EUR | 254.62% |
| 2023 Q4 | 14.25 Million EUR | 0.0% |
| 2023 Q1 | 40.97 Million EUR | 114.0% |
| 2023 Q2 | 40.97 Million EUR | 0.0% |
| 2023 Q3 | 14.25 Million EUR | -65.22% |
| 2023 FY | 14.25 Million EUR | -25.56% |
| 2022 Q2 | 40.55 Million EUR | 0.0% |
| 2022 FY | 19.14 Million EUR | -51.86% |
| 2022 Q4 | 19.14 Million EUR | 0.0% |
| 2022 Q3 | 19.14 Million EUR | -52.79% |
| 2022 Q1 | 40.55 Million EUR | 1.97% |
| 2021 Q1 | 40.61 Million EUR | 26.69% |
| 2021 FY | 39.77 Million EUR | 24.06% |
| 2021 Q4 | 39.77 Million EUR | -0.0% |
| 2021 Q3 | 39.77 Million EUR | -2.07% |
| 2021 Q2 | 40.61 Million EUR | 0.0% |
| 2020 FY | 32.06 Million EUR | 35.8% |
| 2020 Q4 | 32.06 Million EUR | 0.0% |
| 2020 Q3 | 32.06 Million EUR | 4.71% |
| 2020 Q2 | 30.61 Million EUR | -0.0% |
| 2020 Q1 | 30.61 Million EUR | 29.69% |
| 2019 FY | 23.6 Million EUR | -17.72% |
| 2019 Q4 | 23.6 Million EUR | 0.0% |
| 2019 Q2 | 26.15 Million EUR | 0.0% |
| 2019 Q3 | 23.6 Million EUR | -9.73% |
| 2019 Q1 | 26.15 Million EUR | -8.85% |
| 2018 Q3 | 28.69 Million EUR | 0.0% |
| 2018 Q4 | 28.69 Million EUR | 0.0% |
| 2018 FY | 28.69 Million EUR | 44.38% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 19.87 Million EUR | 652.2% |
| 2016 FY | 2.64 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -141.719% |
| Evofem Biosciences, Inc. | 8000.00 USD | -631662.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -2779.043% |
| Mesoblast Limited | 100.29 Million USD | 49.608% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -86085.669% |
| Genus plc | 228.2 Million USD | 77.852% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -7475.896% |
| ContraFect Corporation | 2.21 Million USD | -2186.923% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -3502.522% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -831.377% |
| MultiCell Technologies, Inc. | 36.43 USD | -138734459.429% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | 9.119% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -2170.485% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -4014.507% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | 69.573% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -2562.199% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -29416.44% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -916826.705% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -84.466% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -15595.963% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 99.55% |
| Halberd Corporation | 150 Thousand USD | -33594.0% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -16747.0% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -30679.209% |
| argenx SE | 15.35 Million USD | -229.172% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -148.823% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -1134123.519% |
| Genscript Biotech Corporation | 287.12 Million USD | 82.398% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -39915.993% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -21942.296% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -9013.219% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -199674.695% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -511.58% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -18926.484% |
| ONE Bio Corp. | 592.19 Thousand USD | -8434.477% |
| Reve Technologies, Inc. | 1064.00 USD | -4749993.985% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -33680.93% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -33680.93% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -21903.91% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -35744.681% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -63076.25% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -546.308% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -13594.929% |
| International Stem Cell Corporation | 445 Thousand USD | -11257.528% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -520.135% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -10959.3% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -4253.23% |
| PureTech Health plc | 18.25 Million USD | -176.937% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -33594.0% |
| IXICO plc | 275 Thousand USD | -18278.545% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -326.903% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -92.105% |
| CSL Limited | 11.23 Billion USD | 99.55% |
| Cellectis S.A. | 36.21 Million USD | -39.573% |